BioCentury
ARTICLE | Distillery Techniques

Mayo Clinic liquid biopsy for breast cancer residual disease

August 15, 2019 8:15 PM UTC

A Mayo Clinic team reported that a personalized multiplex sequencing approach called TARDIS (targeted digital sequencing) could accurately distinguish pathological complete response from residual dise...